Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)
- Conditions
- Metastatic Androgen Independent Prostate Cancer
- Interventions
- Biological: APC8015F
- Registration Number
- NCT00849290
- Lead Sponsor
- Dendreon
- Brief Summary
This is an open label, Phase 2 trial of APC8015F immunotherapy in men with objective disease progression on protocol D9902 part B (NCT00065442)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 113
- Objective disease progression
- Subjects must have been enrolled in the APC-Placebo arm of D9902B (NCT00065442)
- Infection requiring IV antibiotics
- Treatment with anticancer interventions within 14 days prior to enrollment
- Any medical condition which could compromise the study's objectives (discretion from sponsor)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description APC8015F APC8015F -
- Primary Outcome Measures
Name Time Method Safety of APC8015F by Review of Reported Adverse Events periodically over 24 months All subjects who received at least one infusion of APC8015F (N = 109) were included in the safety analysis set and were followed for safety. Refer to Serious Adverse Events and Other Adverse Events.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (57)
Georgia Urology, P.A.
🇺🇸Atlanta, Georgia, United States
Princess Margaret Hospital
🇨🇦Toronto, Ontario, Canada
Myron I Murdock MD LLC
🇺🇸Greenbelt, Maryland, United States
Staten Island Urological Research
🇺🇸Staten Island, New York, United States
Sunnybrook & Women's College HSC
🇨🇦Toronto, Ontario, Canada
Hematology/Oncology Associates of the Treasure Coast
🇺🇸Port Saint Lucie, Florida, United States
New York University
🇺🇸New York, New York, United States
Lutheran General Cancer Center
🇺🇸Park Ridge, Illinois, United States
The Urological Institute of Northeastern New York
🇺🇸Albany, New York, United States
Beth Israel Cancer Center
🇺🇸New York, New York, United States
Urology of Virginia, PC
🇺🇸Norfolk, Virginia, United States
Cancer Care Northwest
🇺🇸Spokane, Washington, United States
London Health Sciences Centre
🇨🇦London, Ontario, Canada
Loyola University
🇺🇸Maywood, Illinois, United States
North Shore Hematology Oncology Associates
🇺🇸East Setauket, New York, United States
McKay Urology
🇺🇸Charlotte, North Carolina, United States
Clinical Cancer Center
🇺🇸New York, New York, United States
Mount Sinai School of Medicine
🇺🇸New York, New York, United States
Jefferson Medical College
🇺🇸Philadelphia, Pennsylvania, United States
Mary Crowley
🇺🇸Dallas, Texas, United States
Miami Cancer Center
🇺🇸Miami, Florida, United States
Seattle Cancer Care Alliance
🇺🇸Seattle, Washington, United States
Virginia Mason Medical Center
🇺🇸Seattle, Washington, United States
UCLA
🇺🇸Los Angeles, California, United States
USC Keck School of Medicine
🇺🇸Los Angeles, California, United States
Midwest Prostate & Urology Health Center
🇺🇸Chicago, Illinois, United States
Indiana University
🇺🇸Indianapolis, Indiana, United States
Albany Regional Cancer Center
🇺🇸Albany, New York, United States
Cleveland Clinic Foundation
🇺🇸Cleveland, Ohio, United States
Center for Urologic Care
🇺🇸Bryn Mawr, Pennsylvania, United States
University of Wisconsin, Madison
🇺🇸Madison, Wisconsin, United States
Wenatchee Valley Medical Center
🇺🇸Wenatchee, Washington, United States
Can-Med Medical Research, Inc.
🇨🇦Victoria, British Columbia, Canada
Hospital Notre Dame du CHUM
🇨🇦Montreal, Quebec, Canada
UCSF Cancer Center
🇺🇸San Francisco, California, United States
University of Minnesota
🇺🇸Minneapolis, Minnesota, United States
Duke University Medical Center
🇺🇸Durham, North Carolina, United States
University of Utah
🇺🇸Salt Lake City, Utah, United States
Dana-Farber Cancer Institute
🇺🇸Boston, Massachusetts, United States
Lombardi Cancer Center
🇺🇸Washington, District of Columbia, United States
Grand Strand Urology
🇺🇸Myrtle Beach, South Carolina, United States
Nevada Cancer Institute
🇺🇸Las Vegas, Nevada, United States
Associates in Urology, LLC
🇺🇸West Orange, New Jersey, United States
Lahey Clinic (Department of Urology)
🇺🇸Burlington, Massachusetts, United States
University of Cincinnati
🇺🇸Cincinnati, Ohio, United States
Helen F. Graham Cancer Center
🇺🇸Newark, Delaware, United States
Walter Reid Army Medical Center
🇺🇸Washington, District of Columbia, United States
New York Medical College
🇺🇸Hawthorne, New York, United States
Hackensack University Medical Center
🇺🇸Hackensack, New Jersey, United States
University of Wisconsin
🇺🇸Madison, Wisconsin, United States
Baylor College of Medicine
🇺🇸Houston, Texas, United States
Sutter Cancer Center
🇺🇸Sacramento, California, United States
Kaiser Permanente Medical Group
🇺🇸Portland, Oregon, United States
Mayo Clinic
🇺🇸Rochester, Minnesota, United States
EACRI
🇺🇸Portland, Oregon, United States
St. Luke's Hospital Immunotherapy Program
🇺🇸Milwaukee, Wisconsin, United States
Sharp HealthCare
🇺🇸San Diego, California, United States